These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36891442)

  • 21. Performance of Immunohistochemical and Molecular Methods in Detecting Microsatellite Instability in Gastric Cancer: A Multicenter Study.
    Sousa Marques D; Gullo I; Mascarenhas-Lemos L; Silva JR; Neto do Nascimento C; Pontes P; Pinho L; Cirnes L; Wen X; Cravo M; Carneiro F
    Pathobiology; 2023; 90(6):389-399. PubMed ID: 37271124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers.
    Park Y; Nam SK; Seo SH; Park KU; Oh HJ; Park YS; Suh YS; Ahn SH; Park DJ; Kim HH; Lee HS
    J Gastric Cancer; 2023 Apr; 23(2):264-274. PubMed ID: 37129151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effective screening using a two-antibody panel for detecting mismatch repair deficiency in sporadic colorectal cancer.
    Kim JB; Kim YI; Yoon YS; Kim J; Park SY; Lee JL; Kim CW; Park IJ; Lim SB; Yu CS; Kim JC
    World J Clin Cases; 2021 Aug; 9(24):6999-7008. PubMed ID: 34540955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status].
    Qin Y; Liang L; Zheng X; Zheng J; Ye J; Guo L; Zhao F; Shi X
    Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):704-8. PubMed ID: 26702526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods.
    Yang RK; Chen H; Roy-Chowdhuri S; Rashid A; Alvarez H; Routbort M; Patel KP; Luthra R; Medeiros LJ; Toruner GA
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mismatch Repair Deficient (dMMR) Colorectal Carcinoma in a Pakistani Cohort: Association With Clinical and Pathological Parameters.
    Hashmi AA; Bukhari U; Rizwan R; Faisal F; Kumar R; Malik UA; Zia S; Khan AR; Sham S; Irfan M
    Cureus; 2023 Aug; 15(8):e42781. PubMed ID: 37664303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer.
    Guyot D'Asnières De Salins A; Tachon G; Cohen R; Karayan-Tapon L; Junca A; Frouin E; Godet J; Evrard C; Randrian V; Duval A; Svrcek M; Lascols O; Vignot S; Coulet F; André T; Fléjou JF; Cervera P; Tougeron D
    ESMO Open; 2021 Jun; 6(3):100120. PubMed ID: 33930657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applicability of the FDA-approved Immunohistochemical Panel for Identification of MMRd Phenotype in Uterine Endometrioid Carcinoma.
    Adachi S; Kimata JI; Hanami K; Adachi K; Igarashi T; Liang SG; Ishida Y; Fujino T; Yamazaki K
    Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):24-31. PubMed ID: 37859432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital-based population.
    Ando Y; Kumamoto K; Matsukawa H; Ishikawa R; Suto H; Oshima M; Kamada H; Morishita A; Kobara H; Matsunaga T; Haba R; Masaki T; Suzuki Y; Okano K
    Oncol Lett; 2022 Jan; 23(1):4. PubMed ID: 34820003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantage of
    Berardinelli GN; Scapulatempo-Neto C; Durães R; Antônio de Oliveira M; Guimarães D; Reis RM
    Oncotarget; 2018 Jun; 9(47):28691-28701. PubMed ID: 29983889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.
    de Jong AE; van Puijenbroek M; Hendriks Y; Tops C; Wijnen J; Ausems MG; Meijers-Heijboer H; Wagner A; van Os TA; Bröcker-Vriends AH; Vasen HF; Morreau H
    Clin Cancer Res; 2004 Feb; 10(3):972-80. PubMed ID: 14871975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability.
    Kets CM; van Krieken JH; Hebeda KM; Wezenberg SJ; Goossens M; Brunner HG; Ligtenberg MJ; Hoogerbrugge N
    Br J Cancer; 2006 Dec; 95(12):1678-82. PubMed ID: 17117178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous expression of mismatch repair proteins and interpretation of immunohistochemical results in colorectal cancer and endometrial cancer.
    Li X; Zhang S; Zeng J; Song SS; Liu X; Kang W; Liang M; Yang R; Li H; Liang L
    Pathol Res Pract; 2023 Aug; 248():154647. PubMed ID: 37437501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC.
    Chen J; Yan Q; Sun J; Wang Q; Tao Y; Xiao D; Xie B
    J Cancer; 2023; 14(7):1132-1140. PubMed ID: 37215453
    [No Abstract]   [Full Text] [Related]  

  • 38. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
    Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
    Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Insight into Deficient Mismatch Repair Colorectal Cancer Screening in a Romanian Population-A Bi-Institutional Pilot Study.
    Lungulescu C; Croitoru VM; Volovat SR; Cazacu IM; Turcu-Stiolica A; Gheonea DI; Sur D; Lungulescu CV
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441055
    [No Abstract]   [Full Text] [Related]  

  • 40. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
    Gologan A; Sepulveda AR
    Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.